Clinical Trial

Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System

Study acronym: ENTRUST
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The ENTRUST registry's objective is to collect real-world data (RWD) and health economic data on the ENROUTE™ Transcarotid Neuroprotection System (ENROUTE™ Transcarotid NPS), including populations in which outcomes of TCAR in patients with extracranial carotid artery disease are inadequately reported.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2026-03-03; most recent amendment 2026-07-15.
Trial Details
NCT Number NCT07455747
Lead Sponsor Boston Scientific Corporation
Conditions Extracranial Carotid Artery Disease, TCAR, Transcarotid Artery Revascularization
Enrollment 5,000 participants
Start Date 2026-07
Primary Completion 2028-05 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-16